Post‐Neoadjuvant Chemotherapy Axillary Ultrasound in <scp>cN</scp> + Breast Cancer: Can It Reliably Support de‐Escalation of Axillary Surgery?
AUS following NAC provides only moderate accuracy, with a clinically relevant risk in patients lacking breast response. AUS alone should not determine omission of axillary surgery. A multimodal, biology-informed strategy combining AUS with other imaging techniques is needed to safely guide axillary de-escalation and minimize both overtreatment and undertreatment.
Authors
- Marta Truffi (ORCID: https://orcid.org/0000-0002-1095-4188)
- Daniela Bossi (ORCID: https://orcid.org/0000-0002-7917-0437)
- F Corsi
- Valentina Zanella
- Camilla Rossetti
- Serena Mazzucchelli (ORCID: https://orcid.org/0000-0001-6904-8895)
- Carlo Morasso (ORCID: https://orcid.org/0000-0001-9185-0198)
- Roberta Brancaccio
- Matilde Pelizzola
- Sara Albasini
- Elena Orvieto
- Arianna Bonizzi
Institutions
- University of Milan (IT)
- Istituti Clinici Scientifici Maugeri (IT)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1002/cam4.71759
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00